Effect of Rosuvastatin in Intracerebral Hemorrhage

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of acute phase of intracerebral hemorrhage and if it impact outcome by NIHSS.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidad Autonoma de San Luis Potosí
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Men or Women >16 and < 80 years with ICH and hospital attention in less 24 hours

• Confirmation by CT scan

• Acceptance by family

Exclusion Criteria:

• History of stroke

• History of neurological disease, head injury o psychiatric disorder with disability

• Glasgow less than 9

• Administration 24 hours before: fibrates, niacin, ciclosporin, azoles, macrolides, inhibitors of protease, nefazodone, verapamil, diltiazem, amiodarone.

• Use before hospital of: mannitol, barbiturates, corticosteroids, calcium antagonists

• Any lesion which needs surgery

• Allergy to drug used

• cerebral death

• Hepatic disease (Child B y C) or myopathy (or) history

• Management in other Hospital

• Pregnancy

• ICH major than 60 ml.

• hypothyroidism